Skip to content

DD STOCK

Stock News & Forecast & Price target & Analyst Ratings & Estimates

  • Home
  • technology
  • Unnecessary
  • Health Care
  • Necessary
  • Financials
  • Energy
  • Industrials
  • Basic Materials
  • Telecommunications
  • Utilities
  • Toggle search form

Home » Pfizer » Jefferies raises Pfizer (NYSE:PFE) price target from $38 to $39

Jefferies raises Pfizer (NYSE:PFE) price target from $38 to $39

Posted on October 16, 2023 By legume No Comments on Jefferies raises Pfizer (NYSE:PFE) price target from $38 to $39

Jefferies analyst Akash Tewari upgrades Pfizer (NYSE:PFE) from Hold to Buy and raises the price target from $38 to $39.

Health Care Tags:Pfizer

Post navigation

Previous Post: Wells Fargo lowers Pfizer (NYSE:PFE) price target from $39 to $35
Next Post: UBS announces UnitedHealth Group (NYSE:UNH) $640 price target

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Archives

  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022

Categories

  • Basic Materials
  • Consumer Discretionary
  • Consumer Staples
  • Energy
  • Financials
  • Health Care
  • Industrials
  • Real Estate
  • Technology
  • Telecommunications
  • Uncategorized
  • Utilities

Recent Posts

  • Morgan Stanley raises Micron Technology (NASDAQ:MU) price target from $58.5 to $71.5
  • Intel Soon To Launch AI PC Processors
  • Buy Now Pay Later Helps Drive Online Holiday Spending, Adobe Says
  • 3M Expands Reseller Agreement With Smart Reporting to Include US
  • Analog Devices Entering Later Stages of Downcycle, Morgan Stanley Says

Recent Comments

No comments to show.

Copyright © 2023 DD STOCK.

Powered by PressBook Child WordPress theme